CohBar Announces Changes to its Board of Directors and R&D Leadership

3 years ago

Founding board members transition to reconstituted Scientific Advisory Board Kent Grindstaff, Ph.D. appointed as Senior Vice President of Research MENLO…

Todos Medical Announces “Test & Tollovid®” Holiday Package for Atlanta Area at Provista Diagnostics

3 years ago

Todos Test & Tollovid Holiday Package New York, NY, and Tel Aviv, ISRAEL, Dec. 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire…

Bellerophon Reports Positive Top-Line Data from Phase 2 Acute Dose Escalation Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Sarcoidosis

3 years ago

Phase 2 results provide clinically meaningful reduction in pulmonary vascular resistance; Company intends to design multi-dose Phase 2b trial Treatment…

Xevudy (Sotrovimab) Granted Marketing Authorization by the European Commission for the Early Treatment of COVID-19

3 years ago

LONDON and SAN FRANCISCO, Dec. 17, 2021 (GLOBE NEWSWIRE) -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Nasdaq: VIR)…

C4 Therapeutics Added to NASDAQ Biotechnology Index

3 years ago

WATERTOWN, Mass., Dec. 17, 2021 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company pioneering a…

LifeSci Partnering & Analytics Announces Business Combination with Corsica Life Sciences and Launch of LifeSci Consulting

3 years ago

Business combination with Corsica adds expertise in commercial strategy and market access to established strategy consulting and transaction advisory capabilitiesNEW…

Erasca Announces FDA Clearance of IND Application for ERAS-801 in Glioblastoma Multiforme and Collaboration with GCAR for Potential Inclusion in GBM AGILE Clinical Trial

3 years ago

IND filing achieved ahead of schedule; dosing of first patient in THUNDERBBOLT-1 Phase 1 clinical trial in recurrent GBM anticipated in…

Aquestive Therapeutics Added to NASDAQ Biotechnology Index

3 years ago

WARREN, N.J., Dec. 17, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST), a specialty pharmaceutical company focused on developing and…

Advaxis to Continue to Explore Additional Options to Maximize Stockholder Value

3 years ago

Stockholders approved Proposal 1 in support of Biosight merger Proposal 2 reverse stock split, a condition for completing the merger…

Vincerx Pharma Announces First Patient Dosed in Phase 1 Dose-Escalation Study of VIP152 in Relapsed or Refractory Chronic Lymphocytic Leukemia or Richter Syndrome

3 years ago

PALO ALTO, Calif., Dec. 17, 2021 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address…